BioCentury | Feb 24, 2014
Clinical News

CardioPET: Phase II data

...open-label, Belgian Phase II trial in 15 CAD patients showed that CardioPET was well tolerated. FluoroPharma...
...were presented at the Society of Nuclear Medicine and Molecular Imaging meeting in Palm Springs. FluoroPharma...
BioCentury | Aug 27, 2012
Company News

FluoroPharma management update

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Promoted: Tamara Rhein to CFO from controller WIR Staff...
BioCentury | Jun 25, 2012
Company News

FluoroPharma board of directors update

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Appointed: Thijs Spoor, president and CEO, as chairman; he succeeds David Elmaleh, who departed WIR Staff Diagnostic...
BioCentury | Jul 4, 2011
Financial News

FluoroPharma completes private placement of common stock and warrants

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Date completed: 6/23/11 Type: Private placement of common stock and warrants Raised: $1.6 million Shares: 2 million Price: $0.83 Shares after offering: 13 million Placement agent: Noble...
BioCentury | May 30, 2011
Financial News

FluoroPharma completes private placement of common stock and preferred stock

...$0.83 Shares after offering: 18.2 million Placement agents: Burnham Hill Partners; Monarch Capital Group Note: FluoroPharma...
BioCentury | May 23, 2011
Company News

Commercial E Waste Management, FluoroPharma deal

...to form FluoroPharma Medical Inc. (OTCBB:CEWM). Under the deal, FluoroPharma Inc. shareholders received about 13.9 million FluoroPharma...
...warrants to purchase shares of FluoroPharma Medical. The newco will focus on the development of FluoroPharma's...
...that has also completed Phase I testing. Commercial E Waste Management Inc. (OTCBB:CEWM), Scottsdale, Ariz. FluoroPharma Inc....
BioCentury | Sep 27, 2010
Company News

FluoroPharma management update

FluoroPharma Inc. , Boston, Mass. Business: Diagnostic Hired: Thijs Spoor as CEO and a director, formerly CFO at Sunstone BioSciences Inc. WIR Staff...
BioCentury | Sep 15, 2008
Clinical News

FluoroPharma preclinical data

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....
BioCentury | Sep 15, 2008
Clinical News

FluoroPharma preclinical data

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....
BioCentury | Jul 28, 2008
Clinical News

BFPET: Phase I data

...single injections of BFPET were well tolerated and had rapid blood clearance and myocardial uptake. FluoroPharma Inc....
Items per page:
1 - 10 of 16
BioCentury | Feb 24, 2014
Clinical News

CardioPET: Phase II data

...open-label, Belgian Phase II trial in 15 CAD patients showed that CardioPET was well tolerated. FluoroPharma...
...were presented at the Society of Nuclear Medicine and Molecular Imaging meeting in Palm Springs. FluoroPharma...
BioCentury | Aug 27, 2012
Company News

FluoroPharma management update

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Promoted: Tamara Rhein to CFO from controller WIR Staff...
BioCentury | Jun 25, 2012
Company News

FluoroPharma board of directors update

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Appointed: Thijs Spoor, president and CEO, as chairman; he succeeds David Elmaleh, who departed WIR Staff Diagnostic...
BioCentury | Jul 4, 2011
Financial News

FluoroPharma completes private placement of common stock and warrants

FluoroPharma Medical Inc. (OTCBB:FPMI), Boston, Mass. Business: Diagnostic Date completed: 6/23/11 Type: Private placement of common stock and warrants Raised: $1.6 million Shares: 2 million Price: $0.83 Shares after offering: 13 million Placement agent: Noble...
BioCentury | May 30, 2011
Financial News

FluoroPharma completes private placement of common stock and preferred stock

...$0.83 Shares after offering: 18.2 million Placement agents: Burnham Hill Partners; Monarch Capital Group Note: FluoroPharma...
BioCentury | May 23, 2011
Company News

Commercial E Waste Management, FluoroPharma deal

...to form FluoroPharma Medical Inc. (OTCBB:CEWM). Under the deal, FluoroPharma Inc. shareholders received about 13.9 million FluoroPharma...
...warrants to purchase shares of FluoroPharma Medical. The newco will focus on the development of FluoroPharma's...
...that has also completed Phase I testing. Commercial E Waste Management Inc. (OTCBB:CEWM), Scottsdale, Ariz. FluoroPharma Inc....
BioCentury | Sep 27, 2010
Company News

FluoroPharma management update

FluoroPharma Inc. , Boston, Mass. Business: Diagnostic Hired: Thijs Spoor as CEO and a director, formerly CFO at Sunstone BioSciences Inc. WIR Staff...
BioCentury | Sep 15, 2008
Clinical News

FluoroPharma preclinical data

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....
BioCentury | Sep 15, 2008
Clinical News

FluoroPharma preclinical data

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....
BioCentury | Jul 28, 2008
Clinical News

BFPET: Phase I data

...single injections of BFPET were well tolerated and had rapid blood clearance and myocardial uptake. FluoroPharma Inc....
Items per page:
1 - 10 of 16